小细胞肺癌脑转移患者的立体定向放射外科治疗
本研究回顾性分析立体定向放射外科(SRS)数据库中小细胞肺癌(SCLC)脑转移患者70例、337个病灶,中位生存4.9个月,治疗病灶数与生存相关,1年中枢神经系统控制率在1~2个病灶为39.2%、3~5个为27.6%、>5个为0%,作者认为<5个脑转移灶的SRS可提供可接受的控制率。
要点
- 70例SCLC脑转移患者接受SRS,中位生存4.9个月,治疗病灶中位数4个(范围1-29)。
- 治疗病灶数与生存相关,病灶较少者总生存更优(P < .021)。
- 1年中枢神经系统控制率:1~2个病灶39.2%、3~5个27.6%、>5个0%。
核心结论
- 作者认为,对于脑转移灶<5个的SCLC患者,SRS似乎可提供可接受的控制率。
- 作者认为,脑转移灶>5个的患者后续脑失败率高,不是SRS的理想候选者。
研究设计与样本
- 本研究为对SRS数据库的回顾性分析,评估接受SRS的SCLC患者。
- 共分析70例患者和337个接受治疗的脑转移灶,其中45例既往接受过全脑放疗(WBRT)。
- 接受治疗的脑转移灶中位数为4个(范围1-29)。
主要发现
- 中位生存期为4.9个月(范围0.70-23.9)。
- 治疗脑转移灶数与生存相关,病灶较少的患者总生存改善(P < .021)。
- 治疗脑转移灶数与不同脑失败率相关,1年中枢神经系统控制率在1~2个病灶为39.2%、3~5个为27.6%、>5个为0%。
- 既往接受WBRT的患者脑失败率更差(P < .040)。
- 无既往WBRT的患者1年远隔脑失败率为48%,中位远隔失败时间为15.3个月。
关键数值与推荐
- 1年中枢神经系统控制率:1~2个脑转移灶39.2%,3~5个27.6%,>5个0%。
- 治疗脑转移灶数与生存相关(P < .021),病灶较少者总生存改善。
- 既往WBRT与更差脑失败率相关(P < .040)。
- 无既往WBRT患者1年远隔脑失败率48%,中位远隔失败时间15.3个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Treatment of small cell lung cancer (SCLC) with brain metastatic disease has traditionally involved whole brain radiation therapy (WBRT). The role of stereotactic radiosurgery (SRS) is unclear. METHODS AND MATERIALS: Our study was a retrospective review of an SRS database evaluating patients with SCLC who received SRS. A total of 70 patients and 337 treated brain metastases (BM) were analyzed. Forty-five patients had previous WBRT. The median number of treated BM was 4 (range, 1-29). RESULTS: Median survival was 4.9 months (range, 0.70-23.9). The number of treated BM was correlated with survival; patients with fewer BM had improved overall survival (P < .021). The number of treated BM was associated with different brain failure rates; 1-year central nervous system control rates were 39.2% for 1 to 2 BM, 27.6% for 3 to 5 BM, and 0% for >5 treated BM. Patients with previous WBRT had worse brain failure rates (P < .040). For patients without previous WBRT, the 1-year distant brain failure rate was 48%, and median time to distant failure was 15.3 months. CONCLUSIONS: SRS for SCLC in patients with <5 BM appears to offer acceptable control rates. Patients with >5 BM have high rates of subsequent brain failure and are not ideal candidates for SRS.
引用
- Wang VH, Juneja B, Goldman HW, et al. Stereotactic Radiosurgery for Brain Metastases in Patients With Small Cell Lung Cancer. Adv Radiat Oncol. 2023. PMID: 37408676. doi:10.1016/j.adro.2023.101237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。